Literature DB >> 11579090

Ouabain-induced signaling and vascular smooth muscle cell proliferation.

A Aydemir-Koksoy1, J Abramowitz, J C Allen.   

Abstract

The hypothesis of this study is that the sodium pump complex acts as an intracellular signal-transducing molecule in canine vascular smooth muscle cells through its interaction with other membrane and cytoskeletal proteins. We have demonstrated that 1 nm ouabain induced transactivation of the epidermal growth factor receptor (EGFR), resulting in increased proliferation and bromodeoxyuridine (BrdUrd) uptake. Immunoprecipitation and Western blotting showed that the EGFR and Src were phosphorylated within 5 min of 10(-9) m ouabain stimulation. Both ouabain-induced DNA synthesis (BrdUrd uptake) and MAPK42/44 phosphorylation were inhibited by the Src inhibitor PP2, the EGFR kinase inhibitor AG1478, the tyrosine kinase inhibitor genistein, and the MEK1 inhibitor PD98059. Ouabain concentrations higher than 1 nm had little or no stimulating effect on proliferation or BrdUrd uptake but did minimally activate ERK1/2. Thus, low concentrations of ouabain, which do not inhibit the sodium pump sufficiently to perturb the resting cellular ionic milieu, initiate a transactivational signaling cascade leading to vascular smooth muscle cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579090     DOI: 10.1074/jbc.M106178200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.

Authors:  Changxuan Liu; Yan Bai; Yiliang Chen; Yu Wang; Yoann Sottejeau; Lijun Liu; Xiaomei Li; Jerry B Lingrel; Deepak Malhotra; Christopher J Cooper; Joseph I Shapiro; Zi-jian Xie; Jiang Tian
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 2.  Na(+),K (+)-ATPase as a docking station: protein-protein complexes of the Na(+),K (+)-ATPase.

Authors:  Linda Reinhard; Henning Tidow; Michael J Clausen; Poul Nissen
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

3.  Ouabain attenuates cardiotoxicity induced by other cardiac steroids.

Authors:  M Nesher; U Shpolansky; N Viola; M Dvela; N Buzaglo; H Cohen Ben-Ami; H Rosen; D Lichtstein
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

4.  Identification of hydroxyxanthones as Na/K-ATPase ligands.

Authors:  Zhongbing Zhang; Zhichuan Li; Jiang Tian; Wei Jiang; Yin Wang; Xiaojin Zhang; Zhuorong Li; Qidong You; Joseph I Shapiro; Shuyi Si; Zijian Xie
Journal:  Mol Pharmacol       Date:  2010-03-24       Impact factor: 4.436

5.  Binding of Src to Na+/K+-ATPase forms a functional signaling complex.

Authors:  Jiang Tian; Ting Cai; Zhaokan Yuan; Haojie Wang; Lijun Liu; Michael Haas; Elena Maksimova; Xin-Yun Huang; Zi-Jian Xie
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

Review 6.  The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades.

Authors:  Zhichuan Li; Zijian Xie
Journal:  Pflugers Arch       Date:  2008-02-19       Impact factor: 3.657

7.  Ouabain-stimulated trafficking regulation of the Na/K-ATPase and NHE3 in renal proximal tubule cells.

Authors:  Yanling Yan; Steven Haller; Anna Shapiro; Nathan Malhotra; Jiang Tian; Zijian Xie; Deepak Malhotra; Joseph I Shapiro; Jiang Liu
Journal:  Mol Cell Biochem       Date:  2012-05-23       Impact factor: 3.396

Review 8.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 9.  Regulation of renal function and structure by the signaling Na/K-ATPase.

Authors:  Jeffrey X Xie; Xin Li; Zijian Xie
Journal:  IUBMB Life       Date:  2013-12-10       Impact factor: 3.885

Review 10.  Hormesis and medicine.

Authors:  Edward J Calabrese
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.